These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 10617077)
1. Estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. Endo Y; Yoshimi T; Iijima T; Yamakoshi Y Bioorg Med Chem Lett; 1999 Dec; 9(24):3387-92. PubMed ID: 10617077 [TBL] [Abstract][Full Text] [Related]
2. New estrogenic antagonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. Endo Y; Yoshimi T; Yamakoshi Y Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):312-4. PubMed ID: 10705532 [TBL] [Abstract][Full Text] [Related]
3. Structure-activity study of estrogenic agonists bearing dicarba-closo-dodecaborane. Effect of geometry and separation distance of hydroxyl groups at the ends of molecules. Endo Y; Iijima T; Amakoshi Y; Kubo A; Itai A Bioorg Med Chem Lett; 1999 Dec; 9(23):3313-8. PubMed ID: 10612591 [TBL] [Abstract][Full Text] [Related]
4. Potent estrogen agonists based on carborane as a hydrophobic skeletal structure. A new medicinal application of boron clusters. Endo Y; Iijima T; Yamakoshi Y; Fukasawa H; Miyaura C; Inada M; Kubo A; Itai A Chem Biol; 2001 Apr; 8(4):341-55. PubMed ID: 11325590 [TBL] [Abstract][Full Text] [Related]
5. Protein kinase C modulators bearing dicarba-CLOSO-dodecaborane as a hydrophobic pharmacophore. Endo Y; Yoshimi T; Kimura K; Itai A Bioorg Med Chem Lett; 1999 Sep; 9(17):2561-4. PubMed ID: 10498208 [TBL] [Abstract][Full Text] [Related]
7. Dicarba-closo-dodecaboranes as a pharmacophore. Retinoidal antagonists and potential agonists. Iijima T; Endo Y; Tsuji M; Kawachi E; Kagechika H; Shudo K Chem Pharm Bull (Tokyo); 1999 Mar; 47(3):398-404. PubMed ID: 10212389 [TBL] [Abstract][Full Text] [Related]
8. Potent androgen antagonists based on carborane as a hydrophobic core structure. Fujii S; Goto T; Ohta K; Hashimoto Y; Suzuki T; Ohta S; Endo Y J Med Chem; 2005 Jul; 48(14):4654-62. PubMed ID: 16000001 [TBL] [Abstract][Full Text] [Related]
9. Utility of boron clusters for drug design. Relation between estrogen receptor binding affinity and hydrophobicity of phenols bearing various types of carboranyl groups. Endo Y; Yamamoto K; Kagechika H Bioorg Med Chem Lett; 2003 Nov; 13(22):4089-92. PubMed ID: 14592514 [TBL] [Abstract][Full Text] [Related]
10. Potent estrogenic agonists bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. Endo Y; Iijima T; Yamakoshi Y; Yamaguchi M; Fukasawa H; Shudo K J Med Chem; 1999 May; 42(9):1501-4. PubMed ID: 10229620 [No Abstract] [Full Text] [Related]
11. Modulators of tumor necrosis factor alpha production bearing dicarba-closo-dodecaborane as a hydrophobic pharmacophore. Tsuji M; Koiso Y; Takahashi H; Hashimoto Y; Endo Y Biol Pharm Bull; 2000 Apr; 23(4):513-6. PubMed ID: 10784439 [TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of novel androgen receptor antagonists with sterically bulky icosahedral carboranes. Goto T; Ohta K; Suzuki T; Ohta S; Endo Y Bioorg Med Chem; 2005 Dec; 13(23):6414-24. PubMed ID: 16099660 [TBL] [Abstract][Full Text] [Related]
13. Novel retinoid X receptor (RXR) antagonists having a dicarba-closo-dodecaborane as a hydrophobic moiety. Ohta K; Iijima T; Kawachi E; Kagechika H; Endo Y Bioorg Med Chem Lett; 2004 Dec; 14(23):5913-8. PubMed ID: 15501068 [TBL] [Abstract][Full Text] [Related]
14. Utility of boron clusters for drug design. Hansch-fujita hydrophobic parameters pi of dicarba-closo-dodecaboranyl groups. Yamamoto K; Endo Y Bioorg Med Chem Lett; 2001 Sep; 11(17):2389-92. PubMed ID: 11527738 [TBL] [Abstract][Full Text] [Related]